GE Healthcare has received FDA clearance of Q.Freeze, a PET/CT quantitative imaging technology designed for treatment evaluation earlier in a patient’s cancer treatment.
A new medical isotope project at Los Alamos National Laboratory in New Mexico, has shown promise for producing major quantities of a new cancer-treatment agent, actinium 225 (Ac-225).
GE Healthcare and Dyax have signed a licensing agreement for the development and commercialization of peptides binding to c-Met, which provides upfront, milestone and royalty payments to Dyax. The license includes application of the peptides in PET, SPECT and optical imaging.
Disagreement over management of four high-risk breast lesions—lobular neoplasia, benign papilloma, radial scar and flat epithelial atypia—demonstrate the need for a prospective trial as current recommendations are not well substantiated, according to an article published in the February issue of the American Journal of Roentgenology.
The FDA has cleared features associated with Siemens Healthcare's Biograph mCT PET/CT scanner, which can measure metabolic processes and data quantification, including the assessment of neurological disease, cancerous tissue and cardiac blood flow.
The use of PET imaging increased rapidly from 2004 through 2008 among Medicare beneficiaries diagnosed with cancer, according to a study published in the January issue of Journal of the American College of Radiology. The researchers surmised that PET primarily serves as an additional, rather than replacement, imaging exam.
FDG uptake of thymus measured by PET/CT is an effective indicator for the differentiation of mediastinal lymphoma from normal thymus in pediatric patients, according to a study published online Dec. 12 in Radiology.
Although breast MRI can be used for surgical planning after neoadjuvant chemotherapy, diagnostic accuracy is uneven and is better in more aggressive than in less aggressive cancers, according to a study published in this month's Radiology.
Royal Philips Electronics has received 510(k) clearance from the FDA for its whole-body PET/MR imaging system, the Ingenuity TF PET/MR. The system was on display at the 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 27 to Dec. 2.
CHICAGO--Though bone metastases in neuroendocrine tumors are usually sclerotic with increased bone volume, CT alone depicts only 43 percent of Ga-68-DOTATOC/DOTANOC-positive bone lesions, according to a retrospective analysis presented Nov. 29 at the Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA).
CHICAGO—18F-FLT PET presented much higher specificity than 18F-FDG PET for detecting uterine malignant tumor, and FLT PET correlated to cell proliferation better than FDG PET, based on a small Japanese study presented Nov. 29 at the 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA).
CHICAGO – Mechanistic imaging, which leverages imaging to understand the pathophysiology of disease, will project the specialty of radiology another leap forward, said A. Gregory Sorensen, MD, co-director of Martinos Center for Biomedical Imaging at Massachusetts General Hospital in Boston and CEO of Siemens Healthcare USA, during the Pendergrass New Horizons Lecture Nov. 28 at the 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA).
CHICAGO—Errors in interpretation of ultrasound screening of breast cancer were similar in prevalence (21 percent of misses) to errors in mammographic and MRI interpretation, based on a retrospective review of the ACRIN 6666 trial, presented Nov. 27 at the 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA).
Caliper Life Sciences of Hopkinton, Mass., and Carestream Health of Rochester, N.Y., have settled two lawsuits.
The American Society for Radiation Oncology (ASTRO) has announced the results of its recent election. These new officers will begin their terms at the society’s 53rd annual meeting in Miami Beach, Fla., which will be held Oct. 2-6.
Most primary care physicians (PCPs) are confident in their abilities to provide cancer survivors with adequate follow-up care, an assurance in the skills of PCPs shared by less than one-fourth of oncologists, who see themselves as better-equipped to care for survivors. Meanwhile, both PCPs and oncologists order significantly more screening than professional guidelines recommend.
As many as one-fourth of cases of ductal carcinoma in situ (DCIS) diagnosed using core-needle biopsy are in fact understaged invasive breast cancers, according to a study published in the July issue of Radiology.
Roswell Park Cancer Institute in Buffalo, N.Y., has been named a Center of Quantitative Imaging Excellence by the National Cancer Institute (NCI).
Males are significantly more likely to die from most cancers than females, a risk that mirrors a higher incidence of cancer among men, according to a study published in the August issue of Cancer Epidemiology, Biomarkers & Prevention.
Physician compensation in 2010 flattened, while radiologists faced a decline in average salary, the likely results of dropping reimbursements, according to a survey released this week by Medicus.
|
RSS 
